Adipogen/Rubiginone A2/BVT-0023-M005/5 mg
商品编号：
BVT-0023-M005
品牌：
Adipogen Inc
市场价：
¥9200.00
美元价：
5520.00
产品分类：
其他试剂
公司分类：
Other_reagents
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
| Product Details | |
|---|---|
| Synonyms | Fujianmycin B; SNA 8073A |
| Product Type | Chemical |
| Properties | |
| Formula | C20H16O5 |
| MW | 336.3 |
| CAS | 96695-58-8 |
| Source/Host Chemicals | Isolated from Streptomyces sp. (strain Gö N1/5). |
| Purity Chemicals | ≥98% (HPLC) |
| Appearance | Yellow solid. |
| Solubility | Soluble in DMSO or acetone; slightly soluble in methanol. |
| Identity | Determined by 1H-NMR. |
| Declaration | Manufactured by BioViotica. |
| InChi Key | MUNUJAJWLPOQBH-LZVRBXCZSA-N |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light. |
| Use/Stability |
Stable for at least 1 year after receipt when stored at -20°C. Store solutions at -20°C in the dark. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
- Antibiotic.
- Antibacterial.
- Stereoisomer of SNA 8073B which is a prolyl endopeptidase (PEP) inhibitor.
- Vincristine-induced cytotoxicity potentiating activity against multi-drug-resistant tumor cells.
Product References
- Fujianmycins A and B, new benz[a]anthraquinone antibiotics from a Streptomyces species: R.W. Rickards & J.P. Wu; J. Antibiot. 38, 513 (1985)
- Chemical and biological properties of rubiginone, a complex of new antibiotics with vincristine-cytotoxicity potentiating activity: M. Oka, et al.; J. Antibiot. 43, 967 (1990)
- SNA-8073-B, a new isotetracenone antibiotic inhibits prolyl endopeptidase. I. Fermentation, isolation and biological properties: K. Kimura, et al.; J. Antibiot. 50, 291 (1997)
- Prolyl endopeptidase inhibitors derived from actinomycetes: K. Kimura, et al.; Biosci. Biotechnol. Biochem. 61, 1754 (1997)
- New biologically active rubiginones from Streptomyces sp.: C. Puder, et al.; J. Antibiot. 53, 329 (2000)
品牌介绍
Adipogen公司由三个子公司组成，分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国，运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发，如癌症、免疫、炎症、代谢疾病（糖尿病、肥胖）、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外，也可提供抗体和蛋白产品，Adipogen拥有自己的化学实验室，致力于开发创新型小分子化合物。
联络我们
